GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

GC Biopharma 006280.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

136,700

-2.43%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on GC Biopharma

Our reporting

Next results

23 Mar 2027

Due on 23 Mar 2027. Analysts expect earnings of 1420.52 a share on revenue of ₩519.26bn.

Past results

Reported against what analysts expected

2 Nov 202631 Jul 20268 May 202626 Jan 20263 Nov 20251 Aug 2025
Earnings per share19013.00894.201751.52-7555.401364.763250.62
Forecast2003.02973.79-126.20-3201.46204.79134.55
Revenue₩514.26bn₩421.20bn₩435.50bn₩497.80bn₩609.50bn₩500.30bn
Forecast₩546.87bn₩435.70bn₩439.63bn₩445.57bn₩522.48bn₩489.08bn

Key events

  1. 7 Jun 201321-for-20 share split
  2. 14 Feb 20021-to-0.2 reverse split
  3. 26 Jan 19991-to-0.1864 reverse split
  4. 4 Jan 19931.03-for-1 share split
  5. 1 Aug 1989Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.